146 related articles for article (PubMed ID: 14653826)
1. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.
Fabrizi F; Dulai G; Dixit V; Bunnapradist S; Martin P
Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1071-81. PubMed ID: 14653826
[TBL] [Abstract][Full Text] [Related]
2. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2008 Feb; 15(2):79-88. PubMed ID: 18184190
[TBL] [Abstract][Full Text] [Related]
3. Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Med Virol; 2010 May; 82(5):768-75. PubMed ID: 20336712
[TBL] [Abstract][Full Text] [Related]
4. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
Fabrizi F; Dixit V; Martin P; Messa P
J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
[TBL] [Abstract][Full Text] [Related]
5. Pegylated Interferon Mono-Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta-Analysis.
Fabrizi F; Dixit V; Messa P; Martin P
Ther Apher Dial; 2015 Dec; 19(6):611-21. PubMed ID: 26197927
[TBL] [Abstract][Full Text] [Related]
6. Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety.
Russo MW; Goldsweig CD; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Jul; 98(7):1610-5. PubMed ID: 12873587
[TBL] [Abstract][Full Text] [Related]
7. Interferon therapy of acute hepatitis C in dialysis patients: meta-analysis.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2012 Nov; 19(11):784-91. PubMed ID: 23043385
[TBL] [Abstract][Full Text] [Related]
8. Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2014 Oct; 21(10):681-9. PubMed ID: 25040244
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials.
Fabrizi F; Ganeshan SV; Lunghi G; Messa P; Martin P
J Viral Hepat; 2008 Aug; 15(8):600-6. PubMed ID: 18444984
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients.
Fabrizi F; Lunghi G; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Nov; 24(10):1413-22. PubMed ID: 17081162
[TBL] [Abstract][Full Text] [Related]
11. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.
Hauser G; Awad T; Brok J; Thorlund K; Štimac D; Mabrouk M; Gluud C; Gluud LL
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005441. PubMed ID: 24585509
[TBL] [Abstract][Full Text] [Related]
12. Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection.
Sperl J; Frankova S; Senkerikova R; Neroldova M; Hejda V; Volfova M; Merta D; Viklicky O; Spicak J; Jirsa M
World J Gastroenterol; 2015 May; 21(18):5496-504. PubMed ID: 25987772
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies.
Fabrizi F; Penatti A; Messa P; Martin P
J Med Virol; 2014 Jun; 86(6):933-40. PubMed ID: 24610278
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with peginterferon alpha-2b {12 kDa} for chronic hepatitis C infection in patients undergoing haemodialysis.
Amarapurkar DN; Patel ND; Kirpalani AL
Trop Gastroenterol; 2007; 28(1):16-8. PubMed ID: 17896604
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of factors associated with sustained viral response in patients on hemodialysis treated with standard or pegylated interferon for hepatitis C infection.
Alavian SM; Tabatabaei SV
Iran J Kidney Dis; 2010 Jul; 4(3):181-94. PubMed ID: 20622305
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis.
Mogahed EA; Abdelaziz H; Helmy H; Ghita H; Abdel Mawla MA; Hassanin F; Fadel FI; El-Karaksy H
J Interferon Cytokine Res; 2016 Dec; 36(12):681-688. PubMed ID: 27656950
[TBL] [Abstract][Full Text] [Related]
17. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.
Gordon CE; Uhlig K; Lau J; Schmid CH; Levey AS; Wong JB
Am J Kidney Dis; 2008 Feb; 51(2):263-77. PubMed ID: 18215704
[TBL] [Abstract][Full Text] [Related]
18. Nitazoxanide for chronic hepatitis C.
Nikolova K; Gluud C; Grevstad B; Jakobsen JC
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD009182. PubMed ID: 24706397
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
Liu CH; Kao JH
J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
[TBL] [Abstract][Full Text] [Related]
20. Interferon for interferon naive patients with chronic hepatitis C.
Myers RP; Regimbeau C; Thevenot T; Leroy V; Mathurin P; Opolon P; Zarski JP; Poynard T
Cochrane Database Syst Rev; 2002; 2002(2):CD000370. PubMed ID: 12076394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
